Net Cash Provided by (Used in) Operating Activities |
332M |
USD |
+44.3% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-386M |
USD |
+51.1% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-268M |
USD |
-139% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
100K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
55K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
50 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-322M |
USD |
-348% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
390M |
USD |
+50.6% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Gross |
859M |
USD |
+3.87% |
Q4 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
927M |
USD |
+39.8% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
165M |
USD |
-9.84% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
859M |
USD |
+3.87% |
Q4 2024 |
FY 2024 |
Interest Expense |
2M |
USD |
-100% |
Q2 2025 |
Q2 2025 |